Prenetics Global’s (PRE) Overweight Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Prenetics Global (NASDAQ:PRE) in a research report released on Thursday,Benzinga reports. They currently have a $9.00 price target on the stock.

Prenetics Global Trading Up 1.0 %

PRE opened at $5.99 on Thursday. The firm has a market cap of $54.75 million, a price-to-earnings ratio of -1.50 and a beta of -0.30. Prenetics Global has a 12 month low of $2.85 and a 12 month high of $7.84. The stock has a fifty day moving average price of $5.22 and a 200-day moving average price of $5.09.

About Prenetics Global

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies.